ArticleOncotarget2016

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.

Juan Tornin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.